Related Experiment Videos
Dihydropyrimidine dehydrogenase activity and fluorouracil chemotherapy
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Quantitative Contribution of rs75017182 to Dihydropyrimidine Dehydrogenase mRNA Splicing and Enzyme Activity.
Clinical pharmacology and therapeutics·2017
Novel Deleterious Dihydropyrimidine Dehydrogenase Variants May Contribute to 5-Fluorouracil Sensitivity in an East African Population.
Clinical pharmacology and therapeutics·2016
Clinical Pharmacogenetics Implementation Consortium guidelines for dihydropyrimidine dehydrogenase genotype and fluoropyrimidine dosing.
Clinical pharmacology and therapeutics·2013
A DPYD variant (Y186C) in individuals of african ancestry is associated with reduced DPD enzyme activity.
Clinical pharmacology and therapeutics·2013
Prognostic significance of thymidylate synthase, dihydropyrimidine dehydrogenase and thymidine phosphorylase protein expression in colorectal cancer patients treated with or without 5-fluorouracil-based chemotherapy.
Annals of oncology : official journal of the European Society for Medical Oncology·2008
Pathologic Complete Response (pCR) Rate and Predictors of Response to Taxane, Trastuzumab, and Pertuzumab in HER2‑Positive Breast Cancer: Secondary Analyses of EA1181/CompassHER2 pCR.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026
Therapy for Stage IV Non-Small Cell Lung Cancer With Driver Alterations: ASCO Living Guideline, Version 2026.3.3.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026
Immunotherapy and Targeted Therapy for Advanced Gastroesophageal Cancer: ASCO Living Guideline, Version 2026.1.2.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026
Laser Interstitial Thermal Therapy for Brain Tumors: A Prospective Multicenter Analysis of Patients From the LAANTERN Study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026
Mosunetuzumab With Response-Adapted Polatuzumab Vedotin and Obinutuzumab in Untreated Indolent B-Cell Non-Hodgkin Lymphoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026
COMBI-I: Long-Term Overall Survival With Spartalizumab Plus Dabrafenib and Trametinib in BRAF V600-Mutant Advanced Melanoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026